Novel evidence recently reported by Huang et al. shows that NEDD4L favors the tumor suppressive function and involves in the drug sensitivity in the MM cancer cells, by acting as an autophagy activator (Huang et al. 2022). This evidence concerns the gene NEDD4L and neoplasm.